About Onyx Pharmaceuticals/ PRO Unlimited

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
249 E. Grand Avenue, South San Francisco, CA 94080, US
description icon
Information
Formerly based in South San Francisco, California, Onyx Pharmaceuticals was engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer. Amgen acquired Onyx Pharmaceuticals in 2013. See our Community Guidelines: bit.ly/smcgl

Onyx Pharmaceuticals/ PRO Unlimited Alternatives

Frequently Asked Questions about Onyx Pharmaceuticals/ PRO Unlimited

Who is the CEO of Onyx Pharmaceuticals, Inc., an Amgen subsidiary?

James Douglas is the CEO of Onyx Pharmaceuticals, Inc., an Amgen subsidiary. To contact James Douglas email at [email protected].

Who are the decision makers in Onyx Pharmaceuticals, Inc., an Amgen subsidiary?

The decision makers in Onyx Pharmaceuticals, Inc., an Amgen subsidiary are Frank Hornsby, James Douglas, Lily Zhang, etc. Click to Find Onyx Pharmaceuticals, Inc., an Amgen subsidiary decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more